Teladoc Health, Inc. $TDOC Shares Sold by Entropy Technologies LP

Key Points

• Entropy Technologies LP has significantly reduced its stake in Teladoc Health, Inc., selling 68,499 shares to decrease its holdings by 80% in the first quarter, leaving them with 17,161 shares worth approximately $137,000.
• Despite Entropy's sell-off, other institutional investors like Cambridge Investment Research Advisors and Golden State Wealth Management have increased their positions in Teladoc, showcasing mixed investor sentiment surrounding the stock.
• Teladoc Health's recent earnings report showed better-than-expected results with a revenue of $631.90 million, surpassing analysts' estimates, although it indicates a year-over-year revenue decline of 1.6%.

Entropy Technologies LP lowered its stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 80.0% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 17,161 shares of the health services provider's stock after selling 68,499 shares during the quarter. Entropy Technologies LP's holdings in Teladoc Health were worth $137,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of TDOC. Connor Clark & Lunn Investment Management Ltd. raised its holdings in Teladoc Health by 14.8% in the 1st quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,558,369 shares of the health services provider's stock valued at $12,405,000 after acquiring an additional 200,494 shares during the last quarter. National Bank of Canada FI raised its holdings in Teladoc Health by 79.4% in the 1st quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock valued at $28,000 after acquiring an additional 1,581 shares during the last quarter. Charles Schwab Investment Management Inc. raised its holdings in Teladoc Health by 5.2% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 2,571,673 shares of the health services provider's stock valued at $20,471,000 after acquiring an additional 127,960 shares during the last quarter. Vanguard Group Inc. raised its holdings in Teladoc Health by 7.0% in the 1st quarter. Vanguard Group Inc. now owns 19,752,338 shares of the health services provider's stock valued at $157,229,000 after acquiring an additional 1,289,183 shares during the last quarter. Finally, Monaco Asset Management SAM raised its holdings in Teladoc Health by 22.0% in the 1st quarter. Monaco Asset Management SAM now owns 500,000 shares of the health services provider's stock valued at $3,980,000 after acquiring an additional 90,000 shares during the last quarter. Hedge funds and other institutional investors own 76.82% of the company's stock.

Insider Activity at Teladoc Health

In related news, insider Fernando M. Rodrigues sold 4,174 shares of the stock in a transaction on Tuesday, June 3rd. The stock was sold at an average price of $6.91, for a total value of $28,842.34. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Carlos Nueno sold 3,958 shares of the stock in a transaction on Monday, June 2nd. The shares were sold at an average price of $6.86, for a total value of $27,151.88. Following the completion of the sale, the insider owned 17,645 shares of the company's stock, valued at approximately $121,044.70. This represents a 18.32% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 18,656 shares of company stock worth $128,189. Corporate insiders own 0.58% of the company's stock.

Analyst Ratings Changes

Several research analysts have weighed in on the company. Wells Fargo & Company cut their price target on Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating for the company in a report on Thursday, May 8th. Mizuho assumed coverage on Teladoc Health in a report on Friday, July 25th. They issued a "neutral" rating and a $10.00 price target for the company. Stifel Nicolaus cut their price target on Teladoc Health from $9.00 to $8.00 and set a "hold" rating for the company in a report on Thursday, May 1st. Citigroup cut their price target on Teladoc Health from $11.00 to $8.75 and set a "neutral" rating for the company in a report on Friday, April 25th. Finally, Truist Financial cut their price target on Teladoc Health from $10.00 to $9.00 and set a "hold" rating for the company in a report on Tuesday, May 27th. Six research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $9.75.

Teladoc Health Trading Down 0.5%

Shares of TDOC stock traded down $0.0350 on Thursday, reaching $7.1850. 3,527,114 shares of the stock were exchanged, compared to its average volume of 7,296,003. The stock has a market cap of $1.27 billion, a P/E ratio of -6.04 and a beta of 1.76. The company has a quick ratio of 2.58, a current ratio of 2.67 and a debt-to-equity ratio of 0.70. The firm has a 50 day moving average of $7.72 and a two-hundred day moving average of $8.24. Teladoc Health, Inc. has a 1-year low of $6.35 and a 1-year high of $15.21.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The health services provider reported ($0.19) EPS for the quarter, topping analysts' consensus estimates of ($0.27) by $0.08. The business had revenue of $631.90 million during the quarter, compared to the consensus estimate of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The business's revenue for the quarter was down 1.6% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.38) EPS. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. On average, research analysts anticipate that Teladoc Health, Inc. will post -1.16 EPS for the current year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.